SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 38 filers reported holding SCPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,383 | -31.3% | 756 | -1.7% | 0.00% | – |
| Q2 2023 | $7,836 | -39.6% | 769 | -46.2% | 0.00% | – |
| Q1 2023 | $12,970 | +153.0% | 1,430 | +100.0% | 0.00% | – |
| Q4 2022 | $5,127 | +2.5% | 715 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 715 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 715 | -19.6% | 0.00% | – |
| Q1 2022 | $5,000 | -99.8% | 889 | -99.6% | 0.00% | – |
| Q1 2018 | $2,480,000 | +2.6% | 200,000 | 0.0% | 0.00% | – |
| Q4 2017 | $2,418,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |